Preferred Label : Insulin Glargine;

NCIt related terms : insulin glargine recombinant; Lantus;

NCIt definition : A recombinant human insulin analog with long-acting, blood glucose-lowering activity. Insulin glargine, like regular types of human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin glargine inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin glargine also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05);

Alternative definition : NCI-GLOSS: A drug used to control the amount of sugar in the blood of patients with diabetes. It is a form of the hormone insulin that is made in the laboratory. Insulin glargine controls blood sugar longer than insulin does. It is a type of therapeutic insulin.;

UNII : 2ZM8CX04RZ;

CAS number : 160337-95-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 160337-95-1 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Lantus;

Chemical formula : C267H404N72O78S6;

Codes from synonyms : CDR0000658820; CDR0000658817; CDR0000658818;

Details


Main resources

You can consult :


https://pgtmsite.files.wordpress.com/2024/01/insulineglargine_pgtm_20050922.pdf
2005
Canada
drug information
insulin
Insulin Glargine
Insulin Glargine

---
Nous contacter.
11/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.